Wells Pharmacy Recalls Testosterone Cholesterol Pellets Due to Potency Issues
Wells Pharmacy Network is recalling Testosterone Cholesterol 100 mg pellets because they were found to be superpotent or subpotent.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which the rubric associates with scores of 1 or 2. A score of 2 is assigned because potency deviations in compounded drugs represent a minor labeling or quality control error rather than a cosmetic defect, fitting the 'Minor labeling errors' or 'voluntary precautionary' criteria better than 'Low'.
Plain-English summary
Wells Pharmacy Network, LLC is recalling Testosterone Cholesterol 100 mg Pellets. The recall was initiated because the product was identified as superpotent or subpotent, meaning the drug concentration did not meet the required standards.
The affected product is identified by Lot Number 06072016@5 with a Beyond Use Date of 12/04/2016. The distribution pattern is listed as the U.S.
Consumers who have this product should contact their healthcare provider or the recalling firm for instructions on how to proceed. The FDA has classified this recall as Class III, indicating that use of or exposure to the product is not likely to cause adverse health consequences.
The recalled product
- Product
- Testosterone Cholesterol ,100 mg Pellet, Compounded by: Wells Pharmacy Network
- Manufacturer
- Wells Pharmacy Network, LLC
- Category
- Drug — Compounded Medication
- Hazard
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot Number 06072016@5
- BUD 12/04/2016
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 7 recalled by Wells Pharmacy Network, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same manufacturer · Wells Pharmacy Network, LLC
See all →- SevereWells Pharmacy Recalls Injectable Compounds Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Compounded Chorionic Gonadotropin Injectable Kits
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Compounded Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Trimix with Atropine Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
- SevereWells Pharmacy Recalls Testosterone Cypionate Injectable Due to Sterility Concerns
FDA (Drugs) · 2017-01-11
Same hazard · potency deviation
See all →- ModerateAlendronate Sodium Oral Solution Recalled for Out-of-Specification Assay Results
FDA (Drugs) · 2026-05-06
- HighFDA Recalls Super-Potent Levothyroxine Sodium Tablets Due to Potency Deviation
FDA (Drugs) · 2025-03-26
- HighLevothyroxine Sodium 100 mcg Tablets Recalled for Potency Deviations Nationwide
FDA (Drugs) · 2024-12-18
- HighCloderm Cream Recalled for Manufacturer Quality Assurance Program Discontinuation
FDA (Drugs) · 2024-05-01
- ModerateEsomeprazole Magnesium Capsules Recalled for Out-of-Specification Potency
FDA (Drugs) · 2022-10-05